These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22890053)

  • 1. In vivo effect of proton-pump inhibitors on gastric plasmin-dependent fibrinolysis: a study in a porcine model.
    Thibault A; Marteau P; Drouet L; Lavergne Slove A; Bal dit Sollier C; Camus M; Dray X
    Dig Liver Dis; 2012 Dec; 44(12):995-8. PubMed ID: 22890053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E3710, a new proton pump inhibitor, with a long-lasting inhibitory effect on gastric acid secretion.
    Kodama K; Fujisaki H; Kubota A; Kato H; Hirota K; Kuramochi H; Murota M; Tabata Y; Ueda M; Harada H; Kawahara T; Shinoda M; Watanabe N; Iida D; Terauchi H; Yasui S; Miyazawa S; Nagakawa J
    J Pharmacol Exp Ther; 2010 Aug; 334(2):395-401. PubMed ID: 20484556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric fibrinolysis.
    Nilsson IM; Bergentz SE; Hedner U; Kullenberg K
    Thromb Diath Haemorrh; 1975 Nov; 34(2):409-18. PubMed ID: 807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.
    Mayne GC; Watson DI; Hussey DJ
    ANZ J Surg; 2012 Oct; 82(10):691-6. PubMed ID: 22758658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging.
    Babaei A; Bhargava V; Aalam S; Scadeng M; Mittal RK
    Aliment Pharmacol Ther; 2009 Apr; 29(8):863-70. PubMed ID: 19170660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in gene expression of gastric mucosa during therapeutic acid inhibition.
    Nørsett KG; Laegreid A; Kusnierczyk W; Langaas M; Ylving S; Fossmark R; Myhre S; Falkmer S; Waldum HL; Sandvik AK
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):613-23. PubMed ID: 18679062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
    Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
    Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in gastric pH and in pharmacokinetics of ulipristal acetate - a drug-drug interaction study using the proton pump inhibitor esomeprazole.
    Pohl O; Osterloh I; Lecomte V; Gotteland JP
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):26-33. PubMed ID: 23110788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus.
    Abu-Sneineh A; Tam W; Schoeman M; Fraser R; Ruszkiewicz AR; Smith E; Drew PA; Dent J; Holloway RH
    Aliment Pharmacol Ther; 2010 Oct; 32(8):1023-30. PubMed ID: 20937048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats.
    Benetti C; Flammini L; Vivo V; Colombo P; Colombo G; Elviri L; Scarpignato C; Buttini F; Bettini R; Barocelli E; Rossi A
    J Control Release; 2016 Oct; 239():203-10. PubMed ID: 27574989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of captopril, MK-421 and MK-422 on fibrinolysis determined by 3 "in vitro" assays.
    Ts'ao C; Gardner DV; Galluzzo TS; Molteni A
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):169-76. PubMed ID: 6326700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin-dependent effect of factor V Leiden mutation on the cross-linking of α2-plasmin inhibitor to fibrin and its consequences on fibrinolysis.
    Koncz Z; Bagoly Z; Haramura G; Mezei ZA; Muszbek L
    Thromb Res; 2012 Sep; 130(3):528-34. PubMed ID: 22704462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the area under the plasma concentration vs time curve and the maximum plasma concentration of esomeprazole on intragastric pH.
    Junghard O; Hassan-Alin M; Hasselgren G
    Eur J Clin Pharmacol; 2002 Oct; 58(7):453-8. PubMed ID: 12389067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
    Aoki N; Moroi M; Tachiya K
    Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esomeprazole for the treatment of peptic ulcer bleeding.
    den Hoed CM; Kuipers EJ
    Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):679-95. PubMed ID: 21108587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.